Facing Crisis, Sloan Kettering Tells Exec to Hand Over Profits From Biotech
A vice president at Memorial Sloan Kettering received a stake of nearly $1.4 million in a biotech company for representing the hospital on its board. He will give back his stake as the cancer center grapples with questions about conflicts of interest.
Cancer Center Switches Focus on Fundraising as Problems Mount
The change highlights the challenges facing Memorial Sloan Kettering, one of the nation’s most prestigious cancer centers, amid a widening crisis.
Sloan Kettering’s Cozy Deal With Start-Up Ignites a New Uproar
A for-profit venture with exclusive rights to use the cancer center’s vast archive of tissue slides has generated concerns among pathologists at the hospital, as well as experts in nonprofit law and corporate governance.
Top Official at Memorial Sloan Kettering Resigns After Failing to Disclose Industry Ties
Dr. José Baselga, the hospital’s chief medical officer, stepped down days after a report by ProPublica and the New York Times that he failed to disclose millions of dollars in payments from the health care and drug industry in research articles.
Sloan Kettering Cancer Center Orders Staff to “Do a Better Job” of Disclosing Industry Ties
The move comes after ProPublica and The New York Times reported that one of its top executives failed to report payments from drug and health care companies in dozens of medical journal articles.
Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals
A senior official at Memorial Sloan Kettering Cancer Center has received millions of dollars in payments from companies that are involved in medical research. His omissions expose how weakly conflict-of-interest rules are enforced by journals.
The Price They Pay
ProPublica and The New York Times have partnered to tell the stories of Americans living daily with the reality of high-cost drugs. There are millions of others just like them.
When Buying Prescription Drugs, Some Pay More With Insurance Than Without It
As insurers ask consumers to pay a greater share of their drug costs, it may be cheaper to pay cash than use your insurance card. One expert estimates that consumers could be overpaying for as many as 1 in 10 prescriptions.
How to Save Money on Your Prescription Drugs
Online prescription sites may help you find cheaper prices for some drugs, sometimes without using your insurance.
Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers
Drug companies and doctors have been accused of fueling the opioid crisis, but some question whether insurers have played a role, too.